Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose vs moderate-dose ropivacaine for quadratus lumborum block after percutaneous nephrolithotomy
2020-002699-10Phase 4Terminated
- Start
- Oct 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms). Primary endpoint: Postoperative opioid/morphine dose in PACU. Started Oct 2020; status: terminated.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2020-002699-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002699-10.